Mali vs. Malaria

News that a malaria vaccine was shown to be more than 75% effective in preventing the deadly disease was big news recently.
What flew under the radar? The key contributions of researchers from African countries—where 9 in 10 malaria victims live.
Specifically: Mali’s Malaria Research and Training Center. Phase 3 trials for the R21 vaccine have already started in Mali—and the stakes are high not just for researchers’ careers, but their own communities.
MRTC was co-founded 30 years ago by Ogobara “Ogo” Doumbo, the grandson of traditional healers and one of the first African researchers to lead an international malaria vaccine trial. He died in 2018 but left a legacy of top scientific standards to those he trained.
Smithsonian Magazine

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top